王宁玲律师现任本所上海办公室管理合伙人,她在知识产权各领域具有20多年的丰富经验。其业务涉及专利申办、出具法律意见、尽职调查、客户咨询、许可及专利诉讼,主要业务领域包括化学、化工、制药、医疗设备、半导体材料、3D打印以及纳米技术。
王律师在为跨国公司及中国公司提供知识产权组合管理法律意见、开展尽职调查、提供许可、诉讼和商业秘密保护与维权服务等方面拥有丰富的经验。她参与过多起美国国际贸易委员会(U.S. International Trade Commission,ITC)和美国地区法院的案件,并帮助海外企业在中国进行知识产权维权,包括以司法和海关途径进行维权。
王律师经常在中国和国际会议和研讨会上就专利相关议题发表演讲。她曾在中国人民大学法学院任教美国知识产权法的研究生课程,在上海交通大学凯原法学院任教美国知识产权法的研究生课程并主持专利模拟法庭,在中国科学技术大学担任法律课程项目教授。她目前担任大连理工大学法学院兼职教授。
王律师被《Intellectual Asset Management》评选为中国地区专利交易,专利申办及诉讼业务领域领军律师。《IAM Strategy 300》将她列为顶级知识产权策略师,以表彰其在制定和实施知识产权组合价值最大化战略方面的领先地位。《World IP Review》将她列为世界知识产权评论-中国专利领域领军人。
NOTE: No aspect of these rankings has been approved by the Supreme Court of New Jersey. Further information on methodologies is available via these links.
某特定模块化LED显示面板及其组件案,337-TA-1114(国际贸易委员会)。为多家中国LED企业和其在美国的子公司辩护。
Certain Light Emitting Diode Chips, Laser Diode Chips and Products Containing Same
Defended five Chinese LED companies in ITC litigations.
337-TA-674, ITC, Judge Luckern
Certain Sulfentrazone, Sulfentrazone Compositions, and Processes for Making Sulfentrazone
Defended two Chinese agro-chemical companies, defeating a petition for a temporary exclusion order and prevailing at trial, holding the patent invalid and not infringed.
337-TA-914, ITC, Judge Lord
Certain Plant-Derived Recombinant Human Serum Albumins ("rHSA") and Products Containing Same
337-TA-1238, ITC, Judge McNamara
Prosecuting patents for startup Hutchison Medipharma
Finnegan prepared and prosecuted patents for startup Hutchison Medipharma in the United States for the treatment of metastatic colorectal cancer. Those patents cover a small molecule, fruquintinib, which received approval in China.
Two-Way Radio Equipment and Systems, Related Software, and Components Thereof
337-TA-1053, ITC, Judge McNamara
Certain Short-Wavelength Light Emitting Diodes, Laser Diodes and Products Containing Same
337-TA-640, ITC, Judge Luckern
Conference
5th Intellectual Property Industry Forum 5th Intellectual Property Industry Forum
March 31-April 2
Hangzhou
Award/Ranking
Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked
May 28, 2026
Intellectual Asset Management (IAM)Announcement
Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International
May 4, 2026
Award/Ranking
IAM Recognizes Six Finnegan Partners in its 2026 Global Leaders Guide IAM Recognizes Six Finnegan Partners in its 2026 Global Leaders Guide
October 22, 2025
Intellectual Asset Management (IAM)Award/Ranking
50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000 50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000
June 2, 2025
Intellectual Asset Management (IAM)Award/Ranking
Finnegan Remains a Top Tier Firm in the 2025 Managing Intellectual Property IP Stars Rankings Finnegan Remains a Top Tier Firm in the 2025 Managing Intellectual Property IP Stars Rankings
May 30, 2025
Managing Intellectual PropertyCommentary
IP Leaders Need to Learn and Adapt Fast: LES International President-Elect IP Leaders Need to Learn and Adapt Fast: LES International President-Elect
May 27, 2025
Intellectual Asset Management (IAM)担任俄勒冈州联邦地方法院Ann Aiken法官的法务助理
中文, 英文
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.